University of Illinois at Chicago: Anemia, Sickle Cell trials

The registry lists 14 Anemia, Sickle Cell studies with University of Illinois at Chicago as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 5No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell DiseaseNot yet recruitingNCT07797582Not applicable
• Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, EmpagliflozinRecruitingNCT07175051Phase 2
• Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingNCT03121001Phase 2
• Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility StudyTerminatedNCT04156399Not applicableResults posted
• PATient Navigator to rEduce ReadmissionsCompletedNCT02114515Not applicableResults posted
• Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell DiseaseCompletedNCT00600665Not applicableResults posted
• Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell DiseaseCompletedNCT07402811Not applicable
• Sickle Cell, Pain and Mediterranean DietCompletedNCT06886477Not applicable
• Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease PainCompletedNCT04906447Phase 2
• A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney DiseaseTerminatedNCT04335721Phase 1/2
• Coordinated HEalthcare for Complex KidsCompletedNCT04057521Not applicable
• Glucose Metabolism in Sickle Cell DiseaseActive, not recruitingNCT02922296
• Feasibility of a Stress Reduction Intervention Study in Sickle Cell DiseaseCompletedNCT02501447Not applicable
• Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)Active, not recruitingNCT01499888Phase 1/2